BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 22314397)

  • 1. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
    Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
    Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function.
    Wang M; Gauthier AG; Kennedy TP; Wang H; Velagapudi UK; Talele TT; Lin M; Wu J; Daley L; Yang X; Patel V; Mun SS; Ashby CR; Mantell LL
    Mol Med; 2021 Jul; 27(1):79. PubMed ID: 34271850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice.
    Patel VS; Sitapara RA; Gore A; Phan B; Sharma L; Sampat V; Li JH; Yang H; Chavan SS; Wang H; Tracey KJ; Mantell LL
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):280-7. PubMed ID: 23087050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.
    Hunt WR; Zughaier SM; Guentert DE; Shenep MA; Koval M; McCarty NA; Hansen JM
    Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L43-9. PubMed ID: 24097557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection.
    Sandri A; Lleo MM; Signoretto C; Boaretti M; Boschi F
    Clin Exp Immunol; 2021 Jan; 203(1):87-95. PubMed ID: 32946591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-mediated phagocytic host defense defect in myeloid Cftr-inactivated mice.
    Ng HP; Zhou Y; Song K; Hodges CA; Drumm ML; Wang G
    PLoS One; 2014; 9(9):e106813. PubMed ID: 25184794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis.
    Isopi E; Mattoscio D; Codagnone M; Mari VC; Lamolinara A; Patruno S; D'Aurora M; Cianci E; Nespoli A; Franchi S; Gatta V; Dubourdeau M; Moretti P; Di Sabatino M; Iezzi M; Romano M; Recchiuti A
    Front Immunol; 2020; 11():581. PubMed ID: 32528461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pamoic acid is an inhibitor of HMGB1·CXCL12 elicited chemotaxis and reduces inflammation in murine models of Pseudomonas aeruginosa pneumonia.
    De Leo F; Rossi A; De Marchis F; Cigana C; Melessike M; Quilici G; De Fino I; Mantonico MV; Fabris C; Bragonzi A; Bianchi ME; Musco G
    Mol Med; 2022 Sep; 28(1):108. PubMed ID: 36071400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.
    Palomo J; Marchiol T; Piotet J; Fauconnier L; Robinet M; Reverchon F; Le Bert M; Togbe D; Buijs-Offerman R; Stolarczyk M; Quesniaux VF; Scholte BJ; Ryffel B
    PLoS One; 2014; 9(12):e114884. PubMed ID: 25500839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia.
    Song Z; Kharazmi A; Wu H; Faber V; Moser C; Krogh HK; Rygaard J; Hoiby N
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):882-7. PubMed ID: 9801351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4.
    Tadie JM; Bae HB; Jiang S; Park DW; Bell CP; Yang H; Pittet JF; Tracey K; Thannickal VJ; Abraham E; Zmijewski JW
    Am J Physiol Lung Cell Mol Physiol; 2013 Mar; 304(5):L342-9. PubMed ID: 23316068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection.
    Day BJ; van Heeckeren AM; Min E; Velsor LW
    Infect Immun; 2004 Apr; 72(4):2045-51. PubMed ID: 15039325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction.
    Pène F; Grimaldi D; Zuber B; Sauneuf B; Rousseau C; El Hachem C; Martin C; Belaïdouni N; Balloy V; Mira JP; Chiche JD
    J Infect Dis; 2012 Sep; 206(6):932-42. PubMed ID: 22782952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
    Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.
    Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB
    Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity.
    Riquelme SA; Hopkins BD; Wolfe AL; DiMango E; Kitur K; Parsons R; Prince A
    Immunity; 2017 Dec; 47(6):1169-1181.e7. PubMed ID: 29246444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells.
    Parker D; Cohen TS; Alhede M; Harfenist BS; Martin FJ; Prince A
    Am J Respir Cell Mol Biol; 2012 Jan; 46(1):6-13. PubMed ID: 21778412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK; Radzioch D; Stevenson MM
    Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.